Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ellen Nogueira-Pangrazi"'
Autor:
Raquel Frenedoso da Silva, Ellen Nogueira-Pangrazi, Larissa Akemi Kido, Fabio Montico, Sarah Arana, Dileep Kumar, Komal Raina, Rajesh Agarwal, Valéria Helena Alves Cagnon
Publikováno v:
Journal of Biomedical Science, Vol 24, Iss 1, Pp 1-19 (2017)
Abstract Background In recent times, anti-cancer treatments have focused on Fibroblast Growth Factor (FGF) and Vascular-Endothelial Growth Factor (VEGF) pathway inhibitors so as to target tumor angiogenesis and cellular proliferation. One such drug i
Externí odkaz:
https://doaj.org/article/5702231c280f41cba07a4b2814bf78f0
Autor:
Fabio Montico, Ellen Nogueira Pangrazi, Valéria Helena Alves Cagnon, Raquel Frenedoso da Silva, Larissa Akemi Kido
Publikováno v:
Cell Biology International. 42:153-168
Prostate cancer (PCa) progression mechanism has been linked to epithelial proliferation, tumor invasion ability, and growth factors. Nintedanib (BIBF 1120) has been reported as being FGF and VEGF pathway inhibitors, exhibiting antitumor activity. Thu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9286af2216d951ea741de5bf04e93656
https://doi.org/10.1002/cbin.10881
https://doi.org/10.1002/cbin.10881
Autor:
Ellen Nogueira-Pangrazi, Sarah Arana, Dileep Kumar, Larissa Akemi Kido, Rajesh Agarwal, Raquel Frenedoso da Silva, Fabio Montico, Valéria Helena Alves Cagnon, Komal Raina
Publikováno v:
Journal of Biomedical Science, Vol 24, Iss 1, Pp 1-19 (2017)
Journal of Biomedical Science
Journal of Biomedical Science
Background In recent times, anti-cancer treatments have focused on Fibroblast Growth Factor (FGF) and Vascular-Endothelial Growth Factor (VEGF) pathway inhibitors so as to target tumor angiogenesis and cellular proliferation. One such drug is Ninteda
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c35f2c85c31a45277adfb350e94c4015
http://link.springer.com/article/10.1186/s12929-017-0334-z
http://link.springer.com/article/10.1186/s12929-017-0334-z
Autor:
Ellen, Nogueira Pangrazi, Raquel F, da Silva, Larissa A, Kido, Fabio, Montico, Valéria H A, Cagnon
Publikováno v:
Cell biology international. 42(2)
Prostate cancer (PCa) progression mechanism has been linked to epithelial proliferation, tumor invasion ability, and growth factors. Nintedanib (BIBF 1120) has been reported as being FGF and VEGF pathway inhibitors, exhibiting antitumor activity. Thu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8cd42a7f1975cb32d2b0b6f3e5373f4f
https://pubmed.ncbi.nlm.nih.gov/28980742
https://pubmed.ncbi.nlm.nih.gov/28980742